Literature DB >> 22205086

Road to Alzheimer's disease: the pathomechanism underlying.

R Anand1, Alka Kaushal, Willayat Yousuf Wani, Kiran Dip Gill.   

Abstract

Alzheimer's disease (AD), the most common cause of dementia, results from the interplay of various deregulated mechanisms triggering a complex pathophysiology. The neurons suffer from and slowly succumb to multiple irreversible damages, resulting in cell death and thus memory deficits that characterize AD. In spite of our vast knowledge, it is still unclear as to when the disease process starts and how long the perturbations continue before the disease manifests. Recent studies provide sufficient evidence to prove amyloid β (Aβ) as the primary cause initiating secondary events, but Aβ is also known to be produced under normal conditions and to possess physiological roles, hence, the questions that remain are: What are the factors that lead to abnormal Aβ production? When does Aβ turn into a pathological molecule? What is the chain of events that follows Aβ? The answers are still under debate, and further insight may help us in creating better diagnostic and therapeutic options in AD. The present article attempts to review the current literature regarding AD pathophysiology and proposes a pathophysiologic cascade in AD.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205086     DOI: 10.1159/000332218

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  4 in total

1.  Okadaic Acid and Hypoxia Induced Dementia Model of Alzheimer's Type in Rats.

Authors:  Alka Kaushal; Willayat Yousuf Wani; Amanjit Bal; Kiran Dip Gill; Jyotdeep Kaur
Journal:  Neurotox Res       Date:  2019-02-07       Impact factor: 3.911

Review 2.  Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.

Authors:  Michael F Naso; Brian Tomkowicz; William L Perry; William R Strohl
Journal:  BioDrugs       Date:  2017-08       Impact factor: 5.807

Review 3.  Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.

Authors:  Della Grace Thomas Parambi; Khalid Saad Alharbi; Rajesh Kumar; Seetha Harilal; Gaber El-Saber Batiha; Natália Cruz-Martins; Omnia Magdy; Arafa Musa; Dibya Sundar Panda; Bijo Mathew
Journal:  Mol Neurobiol       Date:  2021-10-15       Impact factor: 5.682

4.  Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.

Authors:  Heike Endepols; Marta Anglada-Huguet; Eckhard Mandelkow; Yannick Schmidt; Philipp Krapf; Boris D Zlatopolskiy; Bernd Neumaier; Eva-Maria Mandelkow; Alexander Drzezga
Journal:  Mol Neurobiol       Date:  2022-03-21       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.